摘要
作者报告近１５年收治的１０４９例特重型、重型颅脑损伤，所有病人格拉斯哥（ＧＣＳ）评分均≤８分。采取手术及药物治疗等综合措施，治愈与好转率为６８．１％，重残率为５．６％，病死率为２６．３％。近６年来，在常规治疗基础上，加用钙拮抗剂尼莫地平治疗５６０例，使治愈和好转率上升为７９．３％，重残率为１．８％，而病死率仅为１８．９％，效果良好。
The authors reviewed 1049 cases of extra-severe or severe craniocerebral trauma in the last 15 years. On the admission tohospital, all the patients had Glasgow Coma Scale score 8. After combined treatment of surgery and medicine, 68.1% of thepatients made cure or good recovery, 5.6% had severe disability, and 26.3% died. In the last 6 years, 560 patients were treated withNimodipine, besides the above routine management. Our clinical trials showed that Nimodipine could remarkably improve thetherapeutic results. The cure and good recovery rate was increased to 79.3%. The severe disability rate and mortality were reduced to1.8% and 18.9% respectively. Some clinical experiences in the treatment of patients with severe craniocerebral trauma aresummedzed and presented in this paper.
出处
《第一军医大学学报》
CSCD
1999年第1期88-90,共3页
Journal of First Military Medical University
关键词
颅脑损伤
尼莫地平
急救
brain injury
intracranial hematoma
Nimodipine
